SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance. - Fazio M; van Rooijen E; Dang M; van de Hoek G; Ablain J; Mito JK; Yang S; Thomas A; Michael J; Fabo T; Modhurima R; Pessina P; et al. (ELife, 2021)